Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

FlyPharma tackles supply chain challenges and industry best practice at another successful conference

October 24, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing flypharma, pharma

For its fifth annual Europe conference, FlyPharma chose Copenhagen as its host city to address the latest supply chain challenges …
News
alkermes

Alkermes to axe 160 jobs in cost-cutting restructure

October 24, 2019 Sales and Marketing

The Irish biopharma company expects to complete most of the job cuts by end of this year and will take …
News
222170359

Damage control: How will pharma manage the health economic impacts of Brexit?

October 23, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HEOR, brexit, health economics and outcomes research, pharma

When it comes to life sciences and patient outcomes, the UK’s destiny is inextricably tied to its relationship with the …
Feature
vertex-headquarters

FDA approves Vertex’s Trikafta in new indication, now potentially covering 90% of cystic fibrosis patients

October 23, 2019 Research and Development, Sales and Marketing FDA, Trikafta, Vertex, cystic fibrosis, pharma

The FDA has granted marketing authorisation to Vertex’s Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) for the treatment of cystic fibrosis (CF), it …
News
brexit-hintergrund_web

“No deal” Brexit and life sciences: What happens?

October 21, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, Europe, UK, brexit, no deal, no-deal, pharma

Prime Minister Boris Johnson may have agreed a withdrawal agreement with the European Union at the 11th hour, but despite …
Feature
alexion_sign

FDA approves Alexion’s Ultomiris in atypical haemolytic uremic syndrome for adults and children

October 21, 2019 Sales and Marketing Alexion, FDA, Ultomiris, pharma, rare disease

The FDA has moved to expand the existing label for Alexion’s Ultomiris (ravulizumab-cwvz) to include the treatment of atypical haemolytic …
News
ema_logo

CHMP recommends several drugs for EU market approval

October 21, 2019 Sales and Marketing

The EMA’s human medicines committee (CHMP) has recommended seven medicines for approval at its October 2019 meet including MSD’s Ervebo, …
News
rocheshanghai

Roche’s Tecentriq/Avastin combo smashes endpoints at Phase 3 in unresectable hepatocellular carcinoma

October 21, 2019 Research and Development, Sales and Marketing Cancer, Roche, immunotherapy, pharma, tecentriq

New Phase 3 data has emerged demonstrating the efficacy of Roche’s Tecentriq (atezolizumab) in combination with Avastin (bevacizumab) in the …
News
astrazeneca_sign_sky

AstraZeneca receives FDA approval for Farxiga

October 21, 2019 Sales and Marketing

AstraZeneca have announced that the US FDA has approved Farxiga (dapagliflozin) to reduce the risk of hospitalisation for heart failure …
News
gsk_boronia_australia

GlaxoSmithKline sells two vaccines for up to £822m

October 21, 2019 Sales and Marketing

GlaxoSmithKline has announced it will divest two of its major vaccines to Denmark-based Bavarian Nordic in a deal that will …
News

Medical cannabis: Growth by leaps and bounds

October 18, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Canada, Canopy Growth, medical cannabis, pharma

This article follows parts one and two of our trio of in-depth pieces focusing on the growing medical cannabis phenomenon. …
Feature
top_10_photo

Top Ten most popular articles on Pharmafile.com this week

October 18, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

It’s time for a rundown of the top 10 articles on PharmaFile this past week. The past seven days saw …
News
dw-anzcxqaqavhl

2019 saw the FDA approve more generic drugs than ever before

October 18, 2019 Medical Communications, Sales and Marketing FDA, US, generic drugs, pharma

Fiscal year 2019 was a record-breaking one, according to the FDA. The US regulator smashed its previous total for annual …
News
andrew_dickinson

Gilead appoints Andrew Dickinson as CFO

October 16, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Gilead Sciences have announced that Andrew Dickinson has been appointed as Chief Financial Officer (CFO) effective 1 November. Dickinson currently …
Appointment
_dsc6281_1

Medical cannabis: Riding the wave

October 16, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kanabo research, medical cannabis, pharma

Following on from our previous piece from Mewburn Ellis on the history of social attitudes towards cannabis, Israel-based Kanabo Research …
Feature
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026